Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275522 · ClinicalTrials.gov registry record · Phase 4
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT00275522: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00275522 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275522, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study is being done to compare the safety and effects (good and bad) of three different combinations of immunosuppression drugs used by kidney transplant recipients while also looking at their kidney function.
Interventions
- DRUG Sirolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275522
The ClinicalTrials.gov registry entry for NCT00275522 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sirolimus is the first listed.
NCT00275522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275522 about?
NCT00275522 is a clinical study titled "The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.". The study is being done to compare the safety and effects (good and bad) of three different combinations of immunosuppression drugs used by kidney transplant recipients while also looking at their kidney function.
What is the current status of trial NCT00275522?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2005-12. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00275522?
The interventions under investigation include: Sirolimus (DRUG).
Who is sponsoring clinical trial NCT00275522?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.